Fundraising Fox
/Companies
Sign in

Ability Pharma

Girona, ES · Founded 2009 · 20 employees on LinkedIn · 3 known investors

Find your way into Ability Pharma

Sign up to see every warm intro you have to Ability Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ability Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs. The company has advanced therapies including ibrilatazar (ABTL0812) through clinical trials for lung cancer, pancreatic cancer, and other tumor types.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Ability Pharma was founded in 2009 by Carles Domenech.

CDCarles Domenech
Carles DomenechFounder · Executive Chairman and Chief Executive OfficerCarles Domenech holds a degree in biology from Universitat Autònoma Barcelona and a Ph.D. in biology, with business training from ESADE; he has spent over 25 years in pharma and biotech business development and licensing roles, including positions at Almirall and Lacer, and has served as CEO and VP of Business Development at Ability Pharma since 2009, where he has advanced the oncology candidate ABTL0812 into international Phase 2b trials.

Investors · 3

CTI Life Sciences Fund L.P.listed by CTI Life Sciences Fund L.P.Montréal

How we know: CTI Life Sciences Fund L.P.'s portfolio page · Not right? Tell us

Inveready Technology Investment Grouplisted by Inveready Technology Investment GroupSan Sebastián · $108K – $21.6M

How we know: a partner's Signal profile · Not right? Tell us

Frequently asked questions

What does Ability Pharma do?
AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs. The company has advanced therapies including ibrilatazar (ABTL0812) through clinical trials for lung cancer, pancreatic cancer, and other tumor types.
Who founded Ability Pharma?
Ability Pharma was founded by Carles Domenech in 2009.
Who are Ability Pharma's investors?
Ability Pharma's investors include Capital Cell, CTI Life Sciences Fund L.P., Inveready Technology Investment Group.
Where is Ability Pharma headquartered?
Ability Pharma is headquartered in Girona, ES.